Respectfully to: Valued Shareholders
According to the schedule sent to Valued Shareholders, Imexpharm Corporation Annual General Meeting of Shareholders would be held on 17th April 2020. However, due to the complication of Covid-19 pandemic and strictly follow the Directive no. 16/CT-TTg of the Prime Minister about social distancing, restriction on traveling to prevent the spread of the pandemic, the Imexpharm Corporation Annual General Meeting of Shareholders is temporarily postponed.
Please download the full document.